Preventive screenings are usually discussed as a patient health issue. For independent medical practices, Medicare and ACA health plans, and the broader healthcare system, the other part of the conversation is that missed screenings are expensive.
When patients fall behind on preventive care, the financial impact doesn’t necessarily show up immediately. When it does appear months or years later, it shows as a more advanced disease, additional treatment, avoidable complications, and higher utilization.
That makes preventive screening an important part of managing long-term healthcare costs.
The Cost Often Comes Later
Chronic disease already represents an enormous share of U.S. healthcare spending. Chronic diseases are a leading driver of the nation’s approximately $5.3 trillion in annual healthcare costs. Consider diabetes.
The CDC estimates the total annual U.S. cost of diabetes at $640 billion, including direct medical expenses and lost productivity. It also reports that 48%–64% of lifetime medical costs for someone with diabetes are associated with complications such as heart disease and stroke.
Screening doesn’t eliminate these costs, but identifying risks and disease earlier allows providers and patients to intervene before conditions become more complicated and potentially more expensive.
Cancer Screening Shows the Financial Value Clearly
Colorectal cancer provides a good example of why the economics of screening matter. A peer-reviewed study examining colorectal cancer screening under commercial insurance and Medicare found that screening is highly cost-effective over a patient’s lifetime.
Researchers also found that Medicare may realize substantial clinical benefits and cost savings from screenings conducted before patients become Medicare beneficiaries. The important point for payers is that the financial value of preventive care does not always remain within a single plan year, or even with a single insurer.
A commercial insurer that pays for preventive care today may see some of the financial benefit appear years later under Medicare. From a systemwide perspective, however, the value of earlier detection remains significant.
Missed Screenings Also Impact Practices
For independent practices, preventive screening gaps also concern practices. A patient who hasn’t received recommended screening may eventually return with a more complex condition that requires additional visits, referrals, care coordination, medication management, hospitalization, or higher costs if the practice is in a value-based care model.
That creates more clinical work and may make it harder for the practice to manage an already busy patient population. Preventive care also creates opportunities for practices to maintain consistent relationships with patients rather than interacting primarily when something goes wrong.
For Medicare populations, the Annual Wellness Visit (AWV) is particularly useful. AWV is a way to develop or update a personalized prevention plan, and it requires an appropriate written screening schedule based on factors including USPSTF recommendations, health status, screening history, and age-appropriate preventive services.
Medicare also covers numerous preventive services, including screenings for cardiovascular disease, diabetes, colorectal cancer, lung cancer, cervical cancer, and breast cancer.
ACA Plans Have Similar Incentives
For ACA and Marketplace populations, cost does not necessarily have to be the barrier patients assume it is. Most ACA health plans must cover specified preventive services, including screening tests, without patient cost sharing when coverage requirements are met, and services are received from an in-network provider.
That makes patient education especially important. If patients don’t understand which preventive services are available through their coverage, a benefit design that prevents or detects disease earlier goes unused.
Closing the Gap Doesn’t Have to Be Complicated
The solution isn’t simply telling patients to “get screened,” but practices and health plans working together to make preventive care easier to complete. That means identifying care gaps before appointments, using EHR reminders, contacting overdue patients, discussing screening during routine visits, making referrals easier to complete, and following up when an ordered screening is not performed.
For health plans, sharing actionable care-gap information with providers helps practices focus their outreach instead of spending valuable staff time determining which patients are overdue.
Prevention Is Also a Financial Strategy
The finances of preventive screening come down to identifying risk earlier, giving healthcare organizations more options and time to manage disease before it becomes serious. Not every screening prevents an expensive diagnosis, and preventive care isn’t automatically cost-saving in every situation.
But strong evidence supports the cost-effectiveness of many recommended screenings, while chronic disease and advanced illness continue to represent enormous financial burdens. For independent practices and ACA and Medicare insurers, improving screening rates isn’t only about meeting a quality measure.
It’s about building a healthcare system that identifies problems sooner, manages resources more effectively, and gives patients a better chance of staying healthy in the first place. Practices that focus on these areas are more likely to succeed over the long term.
Patient Care Health (PCH) partners with carriers and practices to help build the right mindset and systems for real growth. The most successful groups are those whose networks deliver real results, not just good plans.
Reach out to us to get started, and let PCH help you achieve your network goals.
Phone: (866) 985-2010, Monday-Friday 9 A.M. – 5 P.M. CT
Email: info@patientcarehealth.com
